Frank Holler
Chairman bij DELIVRA HEALTH BRANDS INC.
Vermogen: 617 097 $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Ian Mortimer | M | 48 | 11 jaar | |
Michael Hayden | M | 72 |
University of British Columbia
| 41 jaar |
Simon Pimstone | M | 56 | 28 jaar | |
Gord Davey | M | - | 6 jaar | |
Mohammad Azab | M | 68 | 21 jaar | |
Dawn Svoronos | F | 70 | 11 jaar | |
Andy Bayfield | M | - | 5 jaar | |
Jack Tasse | M | - | 4 jaar | |
Paul Lévesque | M | 60 | 4 jaar | |
Clarence Machado | M | 60 | 4 jaar | |
Jocelyn Lafond | M | 56 | 17 jaar | |
Brett Whalen | M | - | 1 jaar | |
Jodi Regts | F | - | 9 jaar | |
Andrew Molson | M | 56 | 4 jaar | |
Frank Shannon | M | - | 3 jaar | |
Marie-Noël Colussi | F | 55 | 27 jaar | |
Philippe Dubuc | M | 57 | 8 jaar | |
Sherry Aulin | F | 40 | 13 jaar | |
Dale MacCandlish-Weil | F | 68 | 7 jaar | |
Jason Bednar | M | 52 | 7 jaar | |
Joseph Arena | M | 69 | 3 jaar | |
Steven Gannon | M | 62 | 9 jaar | |
Gérald A. Lacoste | M | 80 | 18 jaar | |
R. Bustin | M | - |
University of British Columbia
| 47 jaar |
Gary Patou | M | 65 | 20 jaar | |
John Leasure | M | - | 3 jaar | |
Peter Kowal | M | - | 3 jaar | |
Steven Sangha | M | - | 1 jaar | |
Chris von Seggern | M | - | 4 jaar | |
André Dupras | M | 60 | 3 jaar | |
Dale Weil | M | - | 1 jaar | |
Ambrose Hong | M | - |
BC Advantage Funds Ltd.
BC Advantage Funds Ltd. Investment ManagersFinance Founded 2003, BC Advantage Funds (VCC) Ltd is a venture capital firm, headquartered in Canada. | - |
James Empfield | M | - | 8 jaar | |
Orit Segev | M | - |
Genome British Columbia
Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | 15 jaar |
Ágnes Baross | M | - |
Genome British Columbia
Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | 17 jaar |
Patricia Lee | F | - |
Genome British Columbia
Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | 16 jaar |
Robin Sherrington | M | 63 | 23 jaar | |
Christian Marsolais | M | 61 | 17 jaar | |
Shelley McCloskey | F | 64 | 5 jaar | |
Sheila M. Grant | F | - | 4 jaar | |
David P. Charest | M | - |
Genome British Columbia
Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | 19 jaar |
Raymond J. Andersen | M | 76 |
University of British Columbia
| 47 jaar |
Daniel Mahony | M | - | 2 jaar | |
Julie Schneiderman | F | - | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
David Hall | M | 71 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 14 jaar |
Tony Holler | M | 72 |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada.
University of British Columbia
| 18 jaar |
Leonard J. Cox | M | 52 | 2 jaar | |
Lars Ekman | M | 74 | 10 jaar | |
Gordon McCauley | M | - | 9 jaar | |
Gary Bridger | M | 61 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 6 jaar |
David Swetlow | M | - | 8 jaar | |
Ian M. Mallmann | M | 63 |
University of British Columbia
| 11 jaar |
Todd R. Patrick | M | 61 |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | 11 jaar |
Antonio F. Cruz | M | 71 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | - |
Allison Hulme | M | 61 | - | |
Bill Hunter | M | 61 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 19 jaar |
Evan Stein | M | 77 | 8 jaar | |
Kamran Alam | M | 50 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 8 jaar |
Terry Hamilton | M | 61 |
University of British Columbia
| 5 jaar |
Aaron Wong | M | - | 3 jaar | |
Andrew Kain | M | - | 2 jaar | |
John E. Stonier | M | - |
University of British Columbia
| 8 jaar |
Nick Maltchev | M | - | 2 jaar | |
Clarissa Desjardins | M | 57 | - | |
Kwong Choo | M | - | - | |
J. Basil Peters | M | - |
University of British Columbia
| 8 jaar |
Grant Froese | M | 62 | 2 jaar | |
Robert W. R. Bishop | M | - |
University of British Columbia
| 7 jaar |
Mary Garden | F | 65 |
University of British Columbia
| 6 jaar |
Chun Ning Shih | M | 60 |
University of British Columbia
| 6 jaar |
Michael Edward O'Connor | M | - |
University of British Columbia
| 4 jaar |
Martin MacLachlan | M | - |
University of British Columbia
| 5 jaar |
David Nairne | M | - |
University of British Columbia
| 5 jaar |
Peter Wall | M | 48 | 3 jaar | |
Bruce A. Weber | M | - | 7 jaar | |
Debra Milimaka Miles | F | - | - | |
Gregory Burnett | M | - |
University of British Columbia
| 6 jaar |
Kenneth R. Burgess | M | - |
University of British Columbia
| 5 jaar |
Todd Simpson | M | 63 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | - |
Robert E. Pelzer | M | 70 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 6 jaar |
Jeffrey Bacha | M | 56 | 14 jaar | |
William R. Rohn | M | 80 | 3 jaar | |
Ronald Tysoe | M | 71 |
University of British Columbia
| 5 jaar |
Jonathan Leff | M | 55 | 2 jaar | |
Michael M. Tarnow | M | 79 | 22 jaar | |
Gregg Saretsky | M | 64 |
University of British Columbia
| 6 jaar |
P. Reifel | M | 72 |
University of British Columbia
| 6 jaar |
Gary Littlejohn | M | 68 | 5 jaar | |
S. Simpson | M | 67 |
University of British Columbia
| 7 jaar |
Malcolm J. P. Finlayson | M | - |
University of British Columbia
| 7 jaar |
Steven Nizam Khan | M | - |
University of British Columbia
| 7 jaar |
Paul Bowes | M | - |
University of British Columbia
| 4 jaar |
Jack H. L. Miller | M | - |
University of British Columbia
| 6 jaar |
Elaine Jones | M | 69 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 5 jaar |
R. MacKay-Dunn | M | 73 |
Genome British Columbia
Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | 6 jaar |
David de Witt | M | 71 |
University of British Columbia
| 7 jaar |
Suzanne Wood | F | 67 |
University of British Columbia
| 6 jaar |
Richard George Whatley | M | - |
University of British Columbia
| 9 jaar |
David Alan Goodkin | M | - | - | |
Alain Trudeau | M | 64 | 4 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Canada | 100 | 100.00% |
Verenigde Staten | 0 | -.--% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Frank Holler
- Persoonlijk netwerk